Purpose: This study investigates the association between single nucleotide polymorphism in RPL5 and the risk of deep vein thrombosis (DVT) in the Saudi population. Materials and methods: The case-control study included 98 DVT patients and 97 age- and sex-matched healthy controls. Peripheral blood samples were collected for genetic analysis after ethical clearance. DNA extraction was performed using a standard protocol, and RPL5 gene primers were designed for PCR amplification. Sanger sequencing was performed using the ABI 3730×L system. Results: Findings showed a significant correlation between DVT patients and controls for two alleles: RPL5 rs558220259 G (p = 0.000); rs576892621 G (p = 0.031). Genotype analysis showed significant associations for rs138979590 (C/T) (p = 0.0001), rs558220259 (G/A) (p = 0.0087), and rs576892621 (G/A) (p = 0.0272) with DVT. Conclusions: Our findings indicate that variants (rs138979590, rs558220259, and rs576892621) significantly contribute to DVT risk in Saudi patients.
1 December 2025 in International Journal of Innovative Research and Scientific Studies
This study aimed to investigate the serological responses to COVID-19 vaccines in the Saudi population post pandemic, a period characterized by presumed hybrid immunity, and to assess demographic and clinical factors influencing antibody responses. IgG antibody responses to the SARS-CoV-2 spike protein were assessed using chemiluminescent immunoassay (CLIA) in 401 individuals from the Saudi population. Of the 401 participants, 395 were vaccinated and 397 (99%) were positive for anti-SARS-CoV spike protein antibodies, including five of the six unvaccinated individuals. Antibody positivity peaked in ages 20-29 and was lowest in children (0-9 years) and adults over 80 years. IgG levels differed between vaccinated and unvaccinated participants (P < 0.0001) and between sexes (P = 0.0072), but not by vaccine type, dose, or comorbidities. Unexpectedly, vaccinated individuals without prior infection had higher IgG than those with prior infection, challenging the presumed advantage of hybrid immunity. In this Saudi cohort, age and sex significantly influenced spike IgG responses, while vaccine type, dosage, and comorbidities had no effect. Unexpectedly, hybrid immunity showed no advantage, indicating altered immune dynamics at the pandemic’s end. These findings provide valuable insights into population-level COVID-19 immunity and can inform public health strategies and vaccine policies in settings with widespread prior infection or vaccination.